Skip to main content
. 2021 Oct 6;162(12):bqab211. doi: 10.1210/endocr/bqab211

Figure 3.

Figure 3.

Simvastatin reduced c-Myc expression, a downstream signaling target of β-catenin, in human leiomyoma cells. Human leiomyoma cells (HuLM) and primary cells were treated with simvastatin (1uM) for 48 hours. A, Simvastatin significantly reduced the mRNA expression of c-Myc in HuLM cells. B, Simvastatin reduced the protein expression of c-Myc in primary cells as seen in immunohistochemistry. The band was not seen when Western blotting was attempted.